High Content Screening (HCS) and the field of "cellomics" continues to grow from a new technology to an accepted and implemented form of cell-based assay screening in pharmaceutical, biotech, and academic markets. Cellomics™, the creator of and world leader in this technology, has expanded its continuing education curriculum with the addition of the HCS 200 Series of courses that focus on therapeutic areas.
The HCS 200 series of courses are an opportunity for scientists to expand their HCS knowledge and become "power users" within their therapeutic discipline.
HCS202 - HCS for Cancer Applications Part 1
Course Agenda and Content
Day 1
Introduction and Review of Types of Cancer Applications
Cell Cycle Applications
Bioapplications
Reagents
Apoptosis/Necrosis Applications
Bioapplications
Reagents
Plate/Assay Analysis
Time with Cellomics Application and Bioassay Scientists
Day 2
siRNA and miRNA
General Tools to Measure a Variety of siRNA and miRNA
Novel Assay Discussions with a "How-to" Approach
To request information about pricing and registration please contact Cellomics at 1.800.432.4091 (US toll-free) or by email at
Note: Class sizes are limited and courses will be filled on a first come, first serve basis
Upcoming Events
May 17, 2008 ISAC XXIV International Congress Please join us at the International Society for Analytical Cytology's International Congress: Cytometry in the Age of Systems Biology at the Bud ...
Home 
Training 
top